Legislators
Bills
Statements
Lobbying
Travel
Searching...- Lobbying
- Lobbying by RxRevu dba Arrive Health
Lobbying Relationship
Bills mentioned
S.2543: Prescription Drug Pricing Reduction Act of 2019
Sponsor: Charles E. Grassley (R-Iowa)
H.R.3408: Shop Rx Act of 2019
Sponsor: Jodey Arrington (R-Texas)
H.R.3415: Real-Time Beneficiary Drug Cost Bill
Sponsor: Elissa Slotkin (D-Mich.)
H.R.2115: Public Disclosure of Drug Discounts and Real-Time Beneficiary Drug Cost Act
Sponsor: Abigail Spanberger (D-Va.)
H.R.133: Consolidated Appropriations Act, 2021
Sponsor: Henry Cuellar (D-Texas)
H.R.133: David’s Law
Sponsor: Sheila Jackson Lee (D-Texas)
H.R.133: Mandating Exclusive Review of Individual Treatments (MERIT) Act
Sponsor: Vern Buchanan (R-Fla.)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
| Lobbyist | Covered positions? |
|---|---|
| Joel White | Former Staff Director, Ways & Means Healthcare Subcommittee Former Staff Director, Ways and Means Health Subcommittee Former Staff Director, Ways and Means Health Subcommittee; L.A. for Rep. Jim Greenwood; L.A. for Rep. Chris Shays |
| Jennifer Steger | Scheduler/Legislative Assistant, Rep. Jean Schmidt; Executive Assistant/Legislative Assistant, Rep. Jim Gerlach Scheduler/Legislative Assistant, Rep. Jean Schmidt;Executive Assistant/Legislative Assistant, Rep. Jim Gerlach |
| Sloane Salzburg | Health Policy Fellowship for Rep. Phil Gingrey |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate